
South Korean biopharmaceutical company Celltrion has announced that its US branch โ Celltrion USA โ has launched a Humira (adalimumab) …

Eli Lilly and Sigilon Therapeutics have announced a definitive agreement for Lillyโs acquisition of Sigilon, a biopharmaceutical company focusing on …

Danish healthcare company Novo Nordisk has announced that it will invest another DKK 15.9bn into expanding an existing Active Pharmaceutical …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

